Prime Minister Narendra Modi will on Saturday visit the Serum Institute of India (SII) in Pune to take stock of India's progress on the production of coronavirus vaccine 'Covishield', which is being developed by British-Swedish pharmaceutical giant AstraZeneca in collaboration with UK's Oxford University. The SII has partnered with Oxford and AstraZeneca to help with the manufacture and distribution of the COVID-19 vaccine candidate in India. The report was confirmed by Pune Divisional Commissioner Saurav Rao who said PM Modi would be visiting the institute on November 28.

Prime Minister Narendra Modi will on Saturday visit the Serum Institute of India (SII) in Pune to take stock of India's progress on the production of coronavirus vaccine 'Covishield', which is being developed by British-Swedish pharmaceutical giant AstraZeneca in collaboration with UK's Oxford University. The SII has partnered with Oxford and AstraZeneca to help with the manufacture and distribution of the COVID-19 vaccine candidate in India. The report was confirmed by Pune Divisional Commissioner Saurav Rao who said PM Modi would be visiting the institute on November 28.